Cutting Edge Research Group /ID# 236664

Oklahoma City, Oklahoma 73116-1423

0 studies enrolling now · 1 studies all time

What they study most

Autism Spectrum Disorder (ASD), Bipolar I Disorder, Schizophrenia

Studies at this site

• Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder — Completed